Valued at USD 503.72 million in 2025, the lignans market is projected to reach USD 537.11 million in 2026 and USD 912.90 million by 2034, growing at a CAGR of 6.8% during the forecast period 2026–2034. North America was the largest regional market in 2025, and Asia Pacific is expected to grow at the fastest CAGR. In animal nutrition, lignans are valued for immunity-supporting and prebiotic effects, as they may reduce pathogenic bacteria, support intestinal immunity, and help maintain a healthy gut microflora. Key players include Bio-Botanica Inc., BioGin Biochemicals, Biosynth, FarmaSino Pharmaceuticals, Hebei Xinqidian Biotechnology, Kingherbs Ltd., Naturalin Bio-Resources Co., Plamed Green Science Group, Prairie Tide Diversified Inc., Shaanxi Zebrago Industrial, SPI Pharma, TSKG Products LLC, and Xi'an Sinuotebio Tech.
Source Insights: Cereal Production Anchors Supply
By source, the lignans market covers oilseeds, cereals and grains, and plant resins. Cereals and grains dominated in 2025. They are linked to lower rates of cardiovascular and metabolic disease and have antioxidant, anti-inflammatory, and hormone-related effects, including estrogenic, anticarcinogenic, and antiestrogenic properties.
Cereal exports are a major lignan source. In 2023, 17% of total global cereal production was traded internationally, with variation across cereal types. Rising production and consumption of cereals and grains across regions support market growth.
Application Insights: Food and Beverages Expected to Dominate
By application, the market spans cosmetics and toiletries (toiletries, haircare, skincare, and others), food and beverages (dietary supplements, functional beverages, functional foods, and others), animal nutrition, pharmaceuticals, and others. Food and beverages is expected to dominate, driven by functional foods and growing awareness of nutritional benefits.
Browse Insights:
https://www.polarismarketresearch.com/industry-analysis/lignans-market
Functional foods are presented as helping to strengthen immunity and reduce disease risk, and rising incomes and interest in preventive healthcare also support the segment. In cosmetics and toiletries, the shift toward herbal and organic products and anti-aging ingredients is boosting skincare demand. Lignans in animal nutrition continue to be valued for immunity and gut health, supporting intestinal immunity and a healthy gut microflora.
Regional Insights for the Lignans Market
In North America, health concerns have increased R&D investment, with SPI Pharma and Prairie Tide Diversified Inc. named among major companies. Key players are merging, acquiring, and collaborating to strengthen their regional presence. The US holds the largest share in North America, linked to rising breast cancer cases; the American Cancer Society is cited as estimating about 297,790 women and 2,800 men would be diagnosed with breast cancer in 2023. Rising obesity is also increasing demand for healthy diets, reinforcing preventive healthcare priorities.
In Asia Pacific, growth is attributed to cosmetic products and a rising number of manufacturers, as cosmetics makers add lignans to shampoos, anti-aging products, and moisturizers to address dryness and dull skin. Eco-friendly extraction machinery has also increased lignan production, while automation reduces waste, raises yield, and lowers production costs.
Competitive Landscape and Developments
Major players lignan are investing in R&D to expand product lines through new launches, contracts, mergers and acquisitions, investments, and collaborations. Companies aim to offer cost-effective products and often manufacture locally to reduce operating costs. Named participants include Prairie Tide Diversified Inc., SPI Pharma, Biosynth, and Kingherbs Ltd. The report's table of contents also lists regulations and taxation on lignan production as a restraint.
In April 2024, Prairie Tide Diversified strengthened its portfolio of agricultural and natural ingredient products. In May 2024, SPI Pharma appointed IMCD to expand distribution across the Middle East, and in June 2024 Biosynth introduced an automated peptide quotation tool for web account customers, with order tracking and quality control documentation.
For B2B stakeholders, the application mix spanning food and beverages, cosmetics and toiletries, animal nutrition, and pharmaceuticals illustrates the breadth of end-use demand, alongside rising interest in preventive healthcare, while the dominance of cereals and grains as a source underscores the importance of agricultural supply chains.
More Trending Latest Reports By Polaris Market Research:
customer-success-management-market
non-invasive-cancer-diagnostics-market
military-simulation-and-virtual-training-market
viral-vector-and-plasmid-dna-manufacturing-market